MoneyWorks4Me

Sigachi Industries informs about statement of deviation(s) or variation(s)

14 Aug 2023 Evaluate

Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sigachi Industries has informed that it enclosed statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended June 30, 2023, in the prescribed format. The company confirmed that there has been no deviation in the utilization of proceeds of IPO as mentioned in the objects stated in the Prospectus dated November 08, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..